Metropolis Medical Pc

San Francisco, California 94109

0 studies enrolling now · 2 studies all time

What they study most

HIV, HIV, Combination Therapy

Studies at this site

• Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone — Withdrawn before enrolling
• Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients — Completed